# TB-500 FAQ: Side Effects, Safety, BPC-157, Half-Life, Status

> TB-500 FAQ: side effects, long-term safety, the tumor/angiogenesis signal, how it differs from BPC-157, how long it stays in your system, and FDA 503A and WADA status — each answer cited.

The full question set, answered directly and cited where quantitative. The fragment-versus-protein caveat applies to every efficacy answer.

## Identity and use



## Mechanism and effects



## Safety, comparisons, and pharmacokinetics



## Regulatory and access



---

A fiduciary-grade reading of the TB-500 and thymosin beta-4 record — each finding weighed against its own study and graded for evidence, the fragment-versus-protein line drawn in plain sight, with no clinic, pharmacy, or prescription behind the desk and nothing here dispensed or for sale.